Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arch Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Warrants (right to buy) | 20.6K | Aug 31, 2023 | Direct | ||
Arch Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 10.3K | Aug 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARTH | Arch Therapeutics, Inc. | Aug 31, 2023 | 2 | $2.83K | 4 | Sep 8, 2023 | CHIEF FINANCIAL OFFICER |
ARTH | Arch Therapeutics, Inc. | Nov 10, 2022 | 1 | $0 | 4 | Nov 10, 2022 | CHIEF FINANCIAL OFFICER |
ARTH | Arch Therapeutics, Inc. | Jul 6, 2022 | 3 | $0 | 4 | Jul 8, 2022 | CHIEF FINANCIAL OFFICER |
ARTH | Arch Therapeutics, Inc. | Sep 27, 2021 | 1 | $0 | 4 | Oct 1, 2021 | Chief Financial Officer |
ARTH | Arch Therapeutics, Inc. | May 10, 2021 | 0 | $0 | 3 | May 10, 2021 | CFO and Treasurer |